Table 3.
Cox regression analysis for clinical outcomes in RCC patients.
| Characteristics | HR for overall survival | HR for progression-free interval | HE for disease-specific survival |
|---|---|---|---|
| Age (> 60 vs. ≤ 60) | 1.80**** | 1.33 | 1.40 |
| Sex (male vs. female) | 0.93 | 1.52* | 1.22 |
| Stage (stage III/IV vs. stage I/II) | 3.95**** | 6.82**** | 9.83**** |
| Histological grade (grade III/IV vs. stage I/II) | 2.70**** | 3.65**** | 4.79**** |
| T stage (T3–T4 vs. T1–T2) | 3.23**** | 4.52**** | 5.54**** |
| N stage (N1–N2 vs. N0) | 3.45**** | 3.68**** | 3.85**** |
| M stage (M1 vs. M0) | 4.39**** | 8.97**** | 9.11**** |
| Smoker (yes vs. no) | 0.79 | 1.06 | 1.22 |
| RAD54L2 (high vs. low) | 0.60* | 0.60* | 0.54* |
HR hazard ratio; *p < 0.05; ****p < 0.0001.